by In2Pharma | Aug 3, 2023 | News
Belgium The Belgian government has issued a royal decree (19 January 2023) allowing the export of medicines to be temporarily restricted. The decree allows an export in case of unavailability to be subject to prior authorisation, if it concerns essential medicines and...
by In2Pharma | Jun 28, 2023 | News
Belgium The FAMHP again confirms and clarifies their interpretation of the rules set out in Annex 21 in the light of fiscal importation of medicines: “Fiscal importation” means the purchase/procurement ‘on paper’ of medicines that have not left the...
by In2Pharma | Mar 20, 2023 | News
Belgium The FAMHP would like to remind the pharmaceutical industry regarding the following topics: Pictograms related to the environment and recycling (e.g. green dot pictogram) do not comply with art.56§1 of the Royal Decree on medicines. The current guideline...
by In2Pharma | Jun 11, 2020 | News
Belgium Marketing authorisation holders of a medicinal product for human use are required to follow certain guidelines for the labelling and packaging of medicinal products. These guidelines (“Labelling of medicinal products” ) have recently been updated. The main...
by In2Pharma | May 9, 2019 | News
Belgium On February 8, 2019, the Belgian Official Gazette published a Royal Decree amending both the Royal Decree of 14 December 2006 on medicinal products for human and veterinary use and the Royal Decree of 21 January 2009 concerning instructions for pharmacists....
